Dietary therapies for adult and pediatric inflammatory bowel disease
Nutr Clin Pract. 2024 Mar 20. doi: 10.1002/ncp.11146. Online ahead of print.ABSTRACTDiet is an environmental exposure implicated in the development of inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). Dietary therapy is also a tool for management of these conditions. Nutrition therapy for IBD has been shown to reduce intestinal inflammation, promote healing, and alleviate symptoms, as well as improve patients' nutrition status. Although the mechanisms of action of most nutrition therapies for IBD are not well understood, the diets are theorized to eliminate triggers for gut dysbi...
Source: Nutrition in Clinical Practice - March 20, 2024 Category: Nutrition Authors: Jessica Deas Neha D Shah Gauree G Konijeti Abigail Lundin Olivia Lanser Pooja Magavi Sabina Ali Source Type: research
Inflammatory bowel disease is associated with an increase in the incidence of multiple sclerosis: a retrospective cohort study of 24,934 patients
ConclusionThe results of our analysis suggest a notable association between IBD and a subsequent MS diagnosis. These findings warrant further pathophysiological investigation and may have clinical implications for the screening of IBD patients in the future. (Source: European Journal of Medical Research)
Source: European Journal of Medical Research - March 20, 2024 Category: Research Source Type: research
Prebiotics for induction and maintenance of remission in ulcerative colitis
CONCLUSIONS: There may be no difference in occurrence of clinical relapse when adjuvant treatment with prebiotics is compared with adjuvant treatment with placebo for maintenance of remission in UC. Adjuvant treatment with prebiotics may result in more total adverse events when compared to adjuvant treatment with placebo for maintenance of remission. We could draw no conclusions for any of the other outcomes in this comparison due to the very low certainty of the evidence. The evidence for all other comparisons and outcomes was also of very low certainty, precluding any conclusions. It is difficult to make any clear recomm...
Source: Cochrane Database of Systematic Reviews - March 19, 2024 Category: General Medicine Authors: Vassiliki Sinopoulou Morris Gordon Vicki Gregory Anas Saadeh Anthony K Akobeng Source Type: research
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
(Source: Clinical Drug Investigation)
Source: Clinical Drug Investigation - March 19, 2024 Category: Drugs & Pharmacology Source Type: research
Efficacy and safety of filgotinib for ulcerative colitis: A real-world multicenter retrospective study in Japan
CONCLUSIONS: Real-world data demonstrate favourable clinical and safety outcomes of filgotinib for UC.PMID:38494867 | DOI:10.1111/apt.17961 (Source: Herpes)
Source: Herpes - March 18, 2024 Category: Infectious Diseases Authors: Shintaro Akiyama Kaoru Yokoyama Soichi Yagi Shinichiro Shinzaki Kozo Tsuruta Shinichiro Yoshioka Minako Sako Hiromichi Shimizu Mariko Kobayashi Toshiyuki Sakurai Kei Nomura Tomoyoshi Shibuya Masahiro Takahara Sakiko Hiraoka Kyohei Sugai Shunichi Yanai Ats Source Type: research
